Stockholders’ Equity - Reconciliation of Changes in Common Shares Issued and Additional Disclosures (Details)		12 Months Ended
	May 05, 2020 series $ / shares shares	Dec. 31, 2020 $ / shares shares	Dec. 31, 2019 $ / shares shares	May 04, 2020 shares
Common and Preferred Stock
Common stock, shares authorized (in shares)	140,000,000	140,000,000	140,000,000	80,000,000
Common stock, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock. shares authorized (in shares)	100,000	100,000	100,000
Preferred stock, minimum number of series authorized | series	1
Preferred stock, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001	$ 0.0001
Increase (Decrease) in Stockholders' Equity
Shares issued at the beginning of the year (in shares)		63,656,897	62,162,875
Issued upon sale of common stock (in shares)		200,000	0
Stock options exercised (in shares)		111,298	0
Issued in business combination to acquire JP3 (in shares)		11,500,000	0
Shares issued at the end of the year (in shares)		78,669,414	63,656,897
Restricted Stock
Increase (Decrease) in Stockholders' Equity
Issued as restricted stock grants (in shares)		3,114,978	924,022
Restricted Stock Units (RSUs)
Increase (Decrease) in Stockholders' Equity
Issued as restricted stock grants (in shares)		86,241	570,000